Mythic Therapeutics
PrivateLast Round
VC Round
Dec 24, 2024
Total Funding Raised
$126.5M
Company Overview
Mythic Therapeutics operates in Healthcare & Life Sciences and is based in Waltham, Massachusetts. Its latest recorded funding round was a VC Round in December 2024.
Mythic Therapeutics is a biotechnology company that specialized in developing antibody-drug conjugates (ADCs) to deliver chemotherapy directly to tumors, enhancing efficacy while minimizing side effects and toxicity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mythic Therapeutics Comparables
Compare Mythic Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MediLink Therapeutics | 87% | |
| Sutro Biopharma Inc | 80% | |
| Byondis | 78% |
For institutional investors. Book with your work email.
Mythic Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 24, 2024 | ||||
| Series B | Dec 15, 2021 | ||||
| Series A | Aug 13, 2020 |
For institutional investors. Book with your work email.
Mythic Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Refactor Capital | Series B, Series A |
| Perceptive Advisors | Series B |
| Blue Goose Capital | Series B |
| Highside Capital Management | Series B |
| Lifeforce Capital | Series B, Series A |
| Foresite Capital | Series B |
| First Round Capital | Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Presenting Phase 1 KisMET-01 study results at ASCO 2025.
For institutional investors. Book with your work email.
Mythic Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mythic Therapeutics's valuation, stock price, and market status.
Is Mythic Therapeutics a public or private company?
Mythic Therapeutics is a private company.
What is the current stock price of Mythic Therapeutics?
Mythic Therapeutics is a private company, so its shares have no public market price. Caplight tracks Mythic Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mythic Therapeutics worth (valuation)?
Valuation information for Mythic Therapeutics is not publicly available.
Can I buy Mythic Therapeutics stock?
Mythic Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mythic Therapeutics's last funding round?
Mythic Therapeutics's most recent funding round was VC Round on December 24, 2024.
Who are the main investors in Mythic Therapeutics?
Key investors in Mythic Therapeutics include Viking Global Investors, Venrock.
Will Mythic Therapeutics IPO soon?
No public IPO plans have been announced for Mythic Therapeutics.
How can I track Mythic Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Mythic Therapeutics's shares on secondary markets.